| |
|
Displaying releases:
1-15 | 16-30 | 31-45 | 46-60 | 61-63
|
| |
Aug-14-2008
|
Palatin Technologies, Inc. Reports Positive Results of Phase 2a
Clinical Study with PL-3994 for the Treatment of Heart Failure |
| |
Jul-01-2008
|
Palatin Technologies Announces Amendment Expanding AstraZeneca Obesity Collaboration |
| |
May-20-2008
|
Palatin Technologies Initiates Phase 2 Hypertension Clinical Study with PL-3994 |
| |
May-13-2008
|
Palatin Technologies Announces New Strategic Objectives and Reports Third Quarter 2008 Financial Results |
| |
May-08-2008
|
Palatin Technologies to Report Third Quarter, Fiscal Year 2008 Financial Results; Teleconference and Webcast on May 13th |
| |
Mar-10-2008
|
Palatin Technologies, Inc. Reports Positive Results of a Phase I Clinical Study with
PL-3994 for the Treatment of Congestive Heart Failure |
| |
Feb-11-2008
|
Palatin Technologies, Inc. Reports Fiscal Year 2008 Second Quarter Results;
Teleconference and Webcast to be held on February 11, 2008 |
| |
Feb-05-2008
|
Palatin Technologies to Report Second Quarter, Fiscal Year 2008 Financial Results; Teleconference and Webcast on February 11th |
| |
Jan-22-2008
|
Palatin Technologies Announces Litigation Settlement With Competitive Technologies |
| |
Nov-09-2007
|
Palatin Technologies, Inc. Reports Fiscal Year 2008 First Quarter Results; Teleconference and Webcast to be held on November 9, 2007 |
| |
Nov-05-2007
|
Palatin Technologies to Report Fiscal Year 2008 First Quarter Results; Teleconference and Webcast on November 9, 2007 |
| |
Nov-02-2007
|
Palatin Technologies to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference |
| |
Oct-31-2007
|
Palatin Technologies, Inc. Reports Initiation of Human Trials for the Treatment of Congestive Heart Failure |
| |
Sep-27-2007
|
Palatin Technologies, Inc. Reports Positive Data from an At-home Study of Pre- and Postmenopausal Women with Female Sexual Arousal Disorder Treated with Bremelanotide |
| |
Sep-26-2007
|
Palatin Technologies Announces Reduction of Workforce |
| |
 |
|
